Hematopoietic Stem Cell TransplantationTransplantation, AutologousStem Cell TransplantationTransplantation, HomologousTransplantation ConditioningPeripheral Blood Stem Cell TransplantationGraft vs Host DiseaseMultiple MyelomaMelphalanAntineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeStem CellsCombined Modality TherapyHematologic NeoplasmsRemission InductionMyeloablative AgonistsBone Marrow TransplantationRecurrenceLymphoma, Non-HodgkinSalvage TherapyLymphomaDisease-Free SurvivalTransplantation ChimeraBusulfanCyclophosphamideHodgkin DiseaseSurvival RateSurvival AnalysisGraft SurvivalTissue DonorsRetrospective StudiesHematopoietic Stem Cell MobilizationEtoposideCytarabineWhole-Body IrradiationHematopoietic Stem CellsGraft vs Leukemia EffectVidarabineLymphoma, FollicularLiver TransplantationVincristineCarmustineLeukemia, Myeloid, AcutePrognosisGraft vs Tumor EffectHistocompatibility TestingLymphoma, Mantle-CellCord Blood Stem Cell TransplantationFollow-Up StudiesNeoplasm, ResidualThiotepaImmunosuppressive AgentsLymphoma, B-CellBone Marrow PurgingTime FactorsMesenchymal Stem Cell TransplantationAntigens, CD34LeukemiaMyelodysplastic SyndromesAntibodies, Monoclonal, Murine-DerivedLymphocyte TransfusionAntineoplastic AgentsLymphoma, Large B-Cell, DiffuseCell TransplantationDoxorubicinGranulocyte Colony-Stimulating FactorAmyloidosisHistocompatibilitySiblingsPrecursor Cell Lymphoblastic Leukemia-LymphomaLymphoma, T-Cell, PeripheralKidney TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCytomegalovirus InfectionsEmbryonic Stem CellsBoronic AcidsDexamethasoneAntineoplastic Agents, AlkylatingLymphocyte DepletionAntilymphocyte SerumPyrazinesT-LymphocytesMinor Histocompatibility AntigensHepatic Veno-Occlusive DiseaseAdult Stem CellsChimerismAcute DiseaseThalidomideLeukapheresisVirus ActivationPrednisoneLeukemia, MyeloidAutograftsIfosfamideFatal OutcomeAntibodies, MonoclonalHematologic DiseasesProspective StudiesHLA AntigensTransplantation Immunology